Skip to main content
. Author manuscript; available in PMC: 2024 Apr 16.
Published in final edited form as: J Heart Lung Transplant. 2021 Sep 10;41(1):24–33. doi: 10.1016/j.healun.2021.09.001

Table 2.

Characterization of exosome contents from lung transplant recipients with BOS or RAS compared to stable recipients (controls without CLAD). Significantly different proteins (p<0.05) in BOS vs RAS after student’s t-test and multiple testing by Benjamini Hochberg correction.

Exosomal
proteins
Stable
(n=5)
BOS (n=14)
Fold change
RAS (n=13)
Fold change
p values
BOS vs RAS
P-Adj (BH)
Collagen V 1 2.44 3.84 0.0537 0.0690
Kα1 tubulin 1 1.85 1.22 0.0201 0.0301
HLA-DQ 1 1.43 3.35 0.0001 0.0003
HLA-DR 1 3.98 12.05 0.0002 0.00045
HLA class I 1 10.06 11.17 0.5127 0.5127
NFkB 1 3.33 8.08 0.0003 0.00054
CIITA 1 12.5 25.8 0.1434 0.16132
PIGR 1 0.93 2.22 0.0001 0.0003
20S proteasome 1 0.47 1.19 0.0001 0.0003

All values are normalized to CD9 blots. Fold change values are compared to stable (controls without CLAD). p values and p-Adj values are represented after multiple correction test between BOS and RAS LTxR groups.

BOS, bronchiolitis obliterans syndrome; CLAD, chronic lung allograft dysfunction; RAS, restrictive allograft syndrome.